|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ISRCTN |
|
Last refreshed on:
|
12 February 2013 |
|
Main ID: |
ISRCTN71865873 |
|
Date of registration:
|
12/09/2003 |
|
Primary sponsor: |
|
|
Public title:
|
Ultrasound therapy for medial epicondylitis. A double blind randomised placebo controlled trial.
N/A |
|
Scientific title:
|
|
|
Date of first enrolment:
|
Sep 11 2000 |
|
Target sample size:
|
200 |
|
Recruitment status: |
Completed/Not recruiting |
|
URL:
|
http://isrctn.org/ISRCTN71865873 |
|
Study type:
|
Interventional |
|
Study design:
|
Randomised controlled trial
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
Cathy
Speed |
|
Address:
|
Box No 204
Dept of Rheumatology
Addenbrooke's NHS Trust
Hills Road
CB2 2QQ
Cambridge
United Kingdom |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 200 Adults aged 18-75 (PROJ).
Exclusion criteria: Does not match inclusion criteria
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
|
Musculoskeletal Diseases: Medial epicondylitis
|
|
Intervention(s)
|
|
To evaluate the effects of ultrasound in the treatment of medial epicondylitis. Adult subjects with medial epicondylitis will be randomised to receive either ultrasound (US) or sham (S) therapy. In the US group pulsed ultrasound will be delivered at a standardised dosage, initially five times weekly for 3 weeks, then three times weekly for 3 weeks. A single machine will be used and calibrated twice daily. The patient, assessor and treating clinician will all be blinded. Outcome measures will be recorded at 6 weeks and at 9 months from baseline. These will include a forearm evaluation score and pain (primary measures), grip strength, flexibility, inflammation (thermographic score), quality of life and general health status a summary item of status of the injury and a follow up transition item.
|
|
Primary Outcome(s)
|
|
Not provided at time of registration
|
|
Secondary Outcome(s)
|
|
Not provided at time of registration
|
|
Secondary ID(s)
|
|
|
|
N0544093511
|
|
Source(s) of Monetary Support
|
|
Cambridge Consortium - Addenbrooke's (UK)
|
|